Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
COPD
Pharma
Boehringer cuts out-of-pocket inhaler prices to $35 in US
Starting on June 1, patients will only have to shell out a maximum of $35 per month for Boehringer Ingelheim inhalers in the U.S.
Zoey Becker
Mar 7, 2024 11:10am
After FDA says no on Dupixent for hives disorder, Japan says yes
Feb 16, 2024 10:54am
Sanofi, Regeneron score another label expansion for Dupixent
Jan 26, 2024 8:47am
Sanofi, Regeneron's Dupixent scores again in second COPD trial
Nov 27, 2023 10:49am
Lupin scores FDA nod for first generic version of BI's Spiriva
Jun 22, 2023 8:00am
Sanofi pumps up Dupixent and other respiratory pipeline drugs
May 22, 2023 11:00am